Trademark applications and grants for Immunex Corp. Immunex Corp has 95 trademark applications. The latest application filed is for "ENBREL CUBE"
Patent Application | Date |
---|---|
COMPOSITIONS COMPRISING A P75 TUMOR NECROSIS FACTOR RECEPTOR/IG FUSION PROTEIN 20220025016 - 17/392434 Gombotz; Wayne Richard ;   et al. | 2022-01-27 |
COMPOSITIONS COMPRISING A P75 TUMOR NECROSIS FACTOR RECEPTOR/IG FUSION PROTEIN 20190292237 - 16/396352 Gombotz; Wayne Richard ;   et al. | 2019-09-26 |
COMPOSITIONS COMPRISING A P75 TUMOR NECROSIS FACTOR RECEPTOR/IG FUSION PROTEIN 20190144523 - 16/246202 Gombotz; Wayne Richard ;   et al. | 2019-05-16 |
USE OF INTERLEUKIN-4 ANTAGONISTS AND COMPOSITIONS THEREOF 20190023798 - 16/151781 Armitage; Richard J. ;   et al. | 2019-01-24 |
USE OF INTERLEUKIN-4 ANTAGONISTS AND COMPOSITIONS THEREOF 20180171016 - 15/893101 ARMITAGE; Richard J. ;   et al. | 2018-06-21 |
SEC | 0000719529 | IMMUNEX CORP /DE/ of WASHINGTON |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.